Special Issue "Nanomaterials for Biomedical and Biotechnological Applications".

The work of G. Banis et al. [[1]] focuses on the advantages presented by the superparamagnetic feature of iron oxide nanoparticles, highlighting that they are magnetic only when surrounded by a magnetic field. The paper showed how to use two different functionalized nanoparticles, citrate-stabilized and lipid-coated magnetic nanoparticles, in the formation of dehydropeptide-based supramolecular magnetogels. Sánchez et al. [[2]] performed an interesting study on how to produce cubic magnetic nanoparticles with sizes lower than the monodomain critical value while maintaining the supermagnetism critical value, which guarantees no agglomeration and, thus, nanoparticles remain in a colloid state when in solution. The clinical implications of these achievements are several, indeed it is now possible to hypothesise tissue and organ-specific drug administration by conjugating medications to magnetic nanoparticles and subsequently using tuneable magnetic fields to reach the internal target sites. [Extracted from the article]